DocGo Azione

DocGo Debito/EBITDA

Il Rapporto Debiti Totali / EBITDA di DocGo (DCGO) al 10 ago 2026 è 1,00. L'anno precedente, Rapporto Debiti Totali / EBITDA era 1,15 — una variazione del -12,68% (inferiore).

Debito/EBITDA

1,00

YoY

-12,68%

Ultimo aggiornamento:

Rapporto Debiti Totali / EBITDA di DocGo ammonta a 2026 1,00 . Rapporto Debiti Totali / EBITDA di DocGo ammontava a 2025 1,15 . Diminuisce del -12,68% inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

DocGo Analisi delle Azioni

Cosa fa DocGo? The history of DocGo Inc began in 2014 when the idea was born to develop a mobile app for doctor appointment scheduling and health monitoring. The founders recognized a rising demand for faster and more convenient access to medical services. From this vision, DocGo Inc was created. DocGo Inc's business model includes a range of mobile applications that improve access to medical care. The main application is DocGo, which allows users to book doctor appointments and track and manage their health data. This app also offers a feature for monitoring chronic conditions such as diabetes or high blood pressure and automatically sends reports on the status of these conditions to the user's doctor. Another important product from DocGo is the telemedicine system, which allows users to receive early assessments and diagnoses from doctors through video and chat. This helps avoid many cases where patients need to physically visit a doctor, saving time and money. DocGo has also developed a mobile pharmacy app that allows patients to order their medications directly through the app and have them delivered to their homes. This app also has interactive features such as a reminder function that notifies the user when to take their medications. Another important aspect of DocGo is its integration with wearables, which allows users to measure and send their health data to the app in real time. DocGo also utilizes artificial intelligence and machine learning to identify health risks in users and provide recommendations for medications and treatments. In recent years, DocGo has expanded in various areas. The company has formed partnerships with major healthcare organizations and hospitals to create a broader network of care. DocGo has also developed an API that allows other companies to integrate their health data into the DocGo system. Overall, DocGo has made a significant contribution to improving access to medical care, particularly during the COVID-19 pandemic. By providing telemedicine and mobile pharmacy services, as well as managing health data, DocGo has helped democratize and enhance healthcare. DocGo è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su DocGo azioni

Rapporto Debiti Totali / EBITDA di DocGo è 1,00 nel 2026.

Il Rapporto Debiti Totali / EBITDA di DocGo è passato da 1,15 a 1,00, con una variazione del -12,68 %. Il valore è inferiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del DocGo di Rapporto Debiti Totali / EBITDA dal 2006, con valori annuali, grafici e analisi dettagliate.

Debiti/EBITDA misura il debito totale rispetto agli utili prima di interessi, imposte, ammortamenti e accantonamenti. Indica gli anni necessari per ripagare tutto il debito dall'EBITDA.

Un 'buono' varia a seconda del settore e della fase di sviluppo dell'azienda. Su Eulerpool puoi confrontare DocGo di Rapporto Debiti Totali / EBITDA con i competitor del settore e la media industriale per valutare se è attraente.

Access this data via the Eulerpool API

Leva finanziaria — DocGo

Tutte le Metriche Finanziarie — DocGo